1 pixel 1 empty pixel
News on laptop and phone

Boehringer Ingelheim and Markham Headquartered IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

blockchain infographicBURLINGTON, ON and MARKHAM, ON, Feb. 12, 2019 /CNW/ - Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced today at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology in clinical trials.
Categorized in: Business, Information Communications & Technology, Life Sciences & Health Technology, Partnerships Posted on: Last updated on: Written by:

blockchain infographicBURLINGTON, ON and MARKHAM, ON, Feb. 12, 2019 /CNW/ – Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced today at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology in clinical trials.

This collaboration underscores Boehringer Ingelheim’s commitment to healthcare innovation and marks the first time that blockchain technology will be explored in a clinical trial setting in Canada.

Full Article: newswire.ca